Minnesota 2023-2024 Regular Session

Minnesota House Bill HF1665

Introduced
2/13/23  
Refer
2/13/23  

Caption

Minnesota's schedules of controlled substances modified.

Impact

The legislation will revise the definitions of what constitutes controlled substances, allowing for more comprehensive regulation of newly identified drugs. The updated schedules will empower law enforcement and health regulators to track and manage these medications more effectively, which is intended to prevent abuse and ensure public safety. Critics, however, have raised concerns about the implications these changes could have on the availability of necessary medications for those in legitimate need, such as patients who rely on opioids for pain management. The balancing act between control and access remains a contentious issue in ongoing discussions.

Summary

House File 1665 seeks to amend Minnesota's scheduled controlled substances in an effort to mitigate public health concerns surrounding drug abuse and the opioid epidemic. The amendments involve the addition of various substances to the existing schedules outlined in Minnesota Statutes 2022, specifically targeting new synthetic drugs and analogs that have emerged on the market. As drug misuse continues to be a pressing issue, this legislation aims to enhance monitoring and control measures over substances that are increasingly exploited for recreational use, posing health risks to the community.

Contention

Notable points of contention regarding HF1665 include the challenge of harmonizing effective drug regulation with the essential need for patient care. Stakeholders in the medical community voice concerns that overly stringent regulations may limit access to essential medications, leading to potential treatment gaps for patients with chronic pain or other medical conditions. On the other hand, advocates for stricter drug laws point to the necessity of preventing misuse, particularly in light of rising overdose rates associated with opioid and synthetic drug abuse. The discussions in committee have been marked by strong sentiments from both sides, emphasizing the complex dynamics of drug policy.

Companion Bills

MN SF2042

Similar To Minnesota's schedules of controlled substances modification

Previously Filed As

MN SF2042

Minnesota's schedules of controlled substances modification

MN HB1071

Uniform Controlled Substances Act; revise schedules.

MN SB2283

Uniform Controlled Substances Act; revise schedules.

MN HB1467

Uniform Controlled Substances Act; revise schedules.

MN SB2279

Uniform Controlled Substances Act; revise schedules.

MN HB1685

Uniform Controlled Substances Act; revise schedules.

MN HB5

Kratom; include in Schedule I controlled substances list.

MN HB1086

Tianeptine; add to list of Schedule I controlled substances.

MN HB1608

Uniform Controlled Substances Act; include 16 substances in Schedule I.

MN SB2356

Uniform Controlled Substances Act; revise Schedule I.

Similar Bills

MN SF2042

Minnesota's schedules of controlled substances modification

HI SB1186

Relating To The Uniform Controlled Substances Act.

WV SB703

Relating to controlled substances schedule

WV SB179

Relating to controlled substances schedule

IN SB0379

Drug schedules.

WV SB546

Adding and removing certain compounds from controlled substance list

WV HB3434

Relating to the controlled substance schedules and to clean-up errors identified in the code sections

WV SB858

Relating to controlled substance schedules and to clean-up errors identified in code sections